Drug Target Review2025-09-08T09:00:00
By combining human tissue models with explainable AI, researchers can analyse complex patient data to identify which treatments work best for which patients. First applied to inflammatory bowel disease, this approach could improve clinical trial success rates across many diseases.
Already a member? Sign in
By highlighting cutting-edge research and its practical applications, Drug Target Review enables readers to make decisions that accelerate innovation, translate discoveries into therapies, and create tangible benefits for patients worldwide.
By becoming a member you join a connected and collaborative community driving the industry forward. Member benefits include:
2026-08-20T08:43:00Z
Author Dr Daniel Tillett
2024-02-07T14:34:33
Sponsored by BellBrook Labs
2023-03-20T13:41:33
Sponsored by Bio-Techne
2023-07-11T16:13:06
Sponsored by Agilent
2026-05-25T07:00:00
Contributor Professor Neville Sanjana
2023-02-02T11:05:15
Sponsored by Cell Signaling Technology
2024-02-08T11:07:39
Sponsored by Samplix ApS
Site powered by Webvision Cloud